Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Frontiers | Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
Valbenazine tosylate (NBI-98854 tosylate) | VMAT2 Inhibitor | MedChemExpress
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? | CNS Spectrums | Cambridge Core
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine in: Journal of Endocrinology Volume 198 Issue 1 (2008)
VMAT2 gene expression and function as it applies to imaging β-cell mass | SpringerLink
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders - ScienceDirect
Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal Size | Journal of Neuroscience
PDF) Emulating proton-induced conformational changes in the Vesicular monoamine transporter VMAT2 by mutagenesis
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and Amphetamine - ScienceDirect
Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal Size | Journal of Neuroscience
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Tetrabenazine (Ro 1-9569) | VMAT2 Inhibitor | MedChemExpress
Inhibitory co-transmission from midbrain dopamine neurons relies on presynaptic GABA uptake - ScienceDirect
Tetrabenazine Metabolite ((-)-β-Dihydrotetrabenazine) | VMAT2 Inhibitor | MedChemExpress
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders - ScienceDirect
Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal Size | Journal of Neuroscience
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders - ScienceDirect
Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? | CNS Spectrums | Cambridge Core
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other? | CNS Spectrums | Cambridge Core
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity | ACS Chemical Neuroscience
